ProfileGDS4718 / 236871_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 41% 41% 35% 37% 33% 36% 29% 40% 31% 37% 36% 34% 34% 33% 31% 37% 35% 33% 32% 41% 46% 33% 38% 33% 32% 31% 36% 31% 33% 30% 29% 25% 39% 35% 32% 32% 31% 36% 39% 32% 39% 32% 34% 28% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.0304841
GSM549102patient 115, normal, homogenized [OPG study]5.0892741
GSM549104patient 119, normal, homogenized [OPG study]4.7258335
GSM549108patient 138, normal, homogenized [OPG study]4.9122437
GSM549119patient 077, normal, homogenized [OPG study]4.7015333
GSM549133patient 032, cancer, homogenized [OPG study]4.7439236
GSM549139patient 042, cancer, homogenized [OPG study]4.4708429
GSM549099patient 107, normal, homogenized [OPG study]5.0296840
GSM549109patient 139, normal, homogenized [OPG study]4.618731
GSM549110patient 046, normal, homogenized [OPG study]4.8551637
GSM549114patient 063, normal, homogenized [OPG study]4.7409636
GSM549122patient 082, normal, homogenized [OPG study]4.723534
GSM549134patient 033, cancer, homogenized [OPG study]4.6958234
GSM549136patient 036, cancer, homogenized [OPG study]4.6157233
GSM549140patient 044, cancer, homogenized [OPG study]4.5496731
GSM549111patient 047, normal, homogenized [OPG study]4.8322937
GSM549113patient 057, normal, homogenized [OPG study]4.704635
GSM549132patient 031, cancer, homogenized [OPG study]4.6382233
GSM549137patient 038, cancer, homogenized [OPG study]4.6115332
GSM549142patient 047, cancer, homogenized [OPG study]5.1616241
GSM549100patient 110, normal, homogenized [OPG study]5.3282646
GSM549107patient 135, normal, homogenized [OPG study]4.6437233
GSM549115patient 068, normal, homogenized [OPG study]4.8138838
GSM549116patient 072, normal, homogenized [OPG study]4.6442633
GSM549120patient 078, normal, homogenized [OPG study]4.6219132
GSM549131patient 030, cancer, homogenized [OPG study]4.5065631
GSM549118patient 074, normal, homogenized [OPG study]4.7883336
GSM549129patient 027, cancer, homogenized [OPG study]4.5900331
GSM549123patient 088, normal, homogenized [OPG study]4.6745833
GSM549124patient 006, cancer, homogenized [OPG study]4.5951430
GSM549126patient 015, cancer, homogenized [OPG study]4.5047729
GSM549128patient 025, cancer, homogenized [OPG study]4.322625
GSM549103patient 117, normal, homogenized [OPG study]5.0299739
GSM549117patient 073, normal, homogenized [OPG study]4.7132635
GSM549138patient 041, cancer, homogenized [OPG study]4.6083932
GSM549141patient 045, cancer, homogenized [OPG study]4.5614832
GSM549130patient 028, cancer, homogenized [OPG study]4.6183331
GSM549101patient 111, normal, homogenized [OPG study]4.8574936
GSM549105patient 128, normal, homogenized [OPG study]4.9735439
GSM549106patient 134, normal, homogenized [OPG study]4.5687432
GSM549112patient 048, normal, homogenized [OPG study]4.9399339
GSM549125patient 011, cancer, homogenized [OPG study]4.6267532
GSM549127patient 024, cancer, homogenized [OPG study]4.7124934
GSM549135patient 035, cancer, homogenized [OPG study]4.4036528